Cormorant Asset Management

Cormorant Asset Management is a life sciences and healthcare focused investment firm.

Institutional Active Boston, United States Est. 2013
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

Cormorant Asset Management, LP is a life sciences and healthcare focused investment firm, founded by Bihua Chen in 2013. The firm primarily invests in biotechnology companies across public and private markets, employing a long-term, fundamental, and research-intensive approach grounded in deep scientific and therapeutic analysis. Cormorant seeks to identify opportunities where its research may lead to a differentiated view relative to market consensus.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Cormorant Asset Management's primary investment focus?
Cormorant Asset Management specializes in healthcare and life sciences, investing in biotechnology, pharmaceutical, and healthcare technology companies across private and public markets.
When was Cormorant Asset Management founded?
Cormorant Asset Management was founded in 2013.
Which notable companies are in Cormorant Asset Management's portfolio?
Cormorant Asset Management's portfolio includes Chemomab Therapeutics.
Has Cormorant Asset Management had any exits?
Yes, Cormorant Asset Management had an exit in March 2021 with Chemomab Therapeutics, which completed a reverse merger with Anchiano Therapeutics and began trading on NASDAQ.
Who are the key individuals at Cormorant Asset Management?
Bihua Chen is the Founder & CEO, and Raymond Kelleher serves as a Managing Director at Cormorant Asset Management.
What is Cormorant Asset Management's geographic focus for investments?
Cormorant Asset Management is headquartered in Boston, United States, and its portfolio companies include Chemomab Therapeutics and Fore Biotherapeutics.
What is the typical investment stage for Cormorant Asset Management?
Cormorant Asset Management invests in various stages, including C Round, D Round, E Round, and PIPE rounds, with a focus on growth-stage businesses.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)